d-Amphetamine Transdermal System: Phase II started

Hisamitsu's Noven Pharmaceuticals Inc. subsidiary began a double-blind, placebo-controlled, crossover Phase II trial to evaluate d-ATS in about 90 patients ages 6-17 years. ...